Recombinant Protein Inhibitor of Complement Factor 5
- Name
- Recombinant Protein Inhibitor of Complement Factor 5
- Accession Number
- DBCAT005767
- Description
Not Available
- Drugs
Drug Drug Description Nomacopan Nomacopan is under investigation in clinical trial NCT03427060 (Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms). - Drugs & Drug Targets
Drug Target Type